Fenologica
Private Company
Total funding raised: $4.5M
Overview
Fenologica is a private, pre-revenue platform company developing an integrated instrumentation and cloud-based software solution for high-throughput functional cell analysis. Its technology, born from a collaboration with the Pacific Northwest Research Institute (PNRI) and the Dudley Lab, uses continuous multispectral imaging and AI-driven analytics to analyze thousands of microbial samples in situ, reducing experiment time by 10x and cost by 95% compared to legacy methods. The platform addresses a critical bottleneck in synthetic biology and functional genomics by providing rich kinetic and phenotypic data, enabling researchers to understand how genotype influences phenotype. Its initial market is academic and industrial microbiology labs, with long-term applications in pharmaceutical discovery, agriculture, and environmental science.
Technology Platform
Integrated hardware-software-cloud platform for high-throughput, in-situ, multispectral imaging and AI-driven analysis of functional cell assays, initially focused on microbial samples.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Fenologica competes with established life science tool companies offering high-content screening systems (e.g., PerkinElmer, Thermo Fisher) and a growing field of startups focused on lab automation and AI-driven image analysis. Its differentiation lies in the specific application to continuous, in-situ imaging of solid microbial assays at very high density, a niche not fully addressed by generic plate readers or imagers.